Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB L-0501 in Chronic Lymphocytic Leukemia
NCT02042911Phase 2Completed
- Sponsor
- SymBio Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by SymBio Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02042911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042911.